These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 1876819)
61. New drug targets for the treatment of Alzheimer's disease October 9-10, 2003, Philadelphia, PA. Scriabine A CNS Drug Rev; 2004; 10(1):77-82. PubMed ID: 15046014 [No Abstract] [Full Text] [Related]
62. Neuroimmune axis as a basis of therapy in Alzheimer's disease. Singh VK Prog Drug Res; 1990; 34():383-93. PubMed ID: 2236570 [No Abstract] [Full Text] [Related]
63. Our Journey with Alzheimer's Disease: A Love Story. Weikart S Narrat Inq Bioeth; 2020; 10(2):E11-E14. PubMed ID: 33416563 [No Abstract] [Full Text] [Related]
64. Treating Alzheimer's disease with cholinergic drugs, Part I. Terpstra T; Terpstra T Nurse Pract; 1998 Nov; 23(11):90, 92, 97 passim. PubMed ID: 9834506 [No Abstract] [Full Text] [Related]
65. Pharmacoepidemiology of tacrine in Alzheimer's disease. Begaud B; Haramburu F; Miremont G Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():77-8. PubMed ID: 8899701 [No Abstract] [Full Text] [Related]
66. [Clinical study of patients with Alzheimer's disease under treatment with tacrine]. García-López MT; Guardado-Santervás P Rev Neurol; 2001 Feb 16-28; 32(4):394-7. PubMed ID: 11398762 [No Abstract] [Full Text] [Related]
67. Love and terror. Is a chemical messenger key to treating Alzheimer's? Erickson D Sci Am; 1991 Apr; 264(4):148, 150. PubMed ID: 1876819 [No Abstract] [Full Text] [Related]
68. Alzheimer's disease: the role of tacrine therapy. Jogerst G Iowa Med; 1995 Oct; 85(10):409-11. PubMed ID: 7591656 [No Abstract] [Full Text] [Related]